Official Journal of Research Center for Gastroenterology and Liver Diseases
OpenAlex
Works that cite this article, indexed by OpenAlex.
Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma
Royal Society Open Science 5(12) (2018)
Otília Menyhárt; Ádám M. Nagy; Balázs Győrffy
The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis
PLoS ONE 15(2) (2020)
Jiaxin Zhang; Guang Chen; Peng Zhang; Jiaying Zhang; Xiaoke Li; Danan Gan; Xu Cao; Mei Han; Hongbo Du; Yongan Ye
Biomarkers for Hepatocellular Carcinoma
Biomarkers in Cancer 9 (2017)
Jiatao Lou; Ling-Fei Zhang; Shaogang Lv; Chenzi Zhang; Shuai Jiang
Biomarker development for hepatocellular carcinoma early detection: current and future perspectives
Hepatic Oncology 4(4) (2017)
Shreya Sengupta; Neehar D. Parikh
Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease
Cochrane Database of Systematic Reviews 2021(4) (2021)
Agostino Colli; Tin Nadarević; Damir Miletić; Vanja Giljača; Mirella Fraquelli; Davor Štimac; Giovanni Casazza
Proteomic Profiling and Artificial Intelligence for Hepatocellular Carcinoma Translational Medicine
Biomedicines 9(2) (2021)
Nurbubu T. Moldogazieva; Innokenty M. Mokhosoev; Sergey Pavlovich Zavadskiy; Alexander A. Terentiev
An updated overview on hepatocellular carcinoma in patients with Metabolic dysfunction-Associated Steatotic Liver Disease: Trends, pathophysiology and risk-based surveillance
Metabolism 162 (2024)
Angelo Armandi; Chiara Rosso; Gian Paolo Caviglia; Elisabetta Bugianesi
Biomarkers for Hepatocellular Carcinoma: From Origin to Clinical Diagnosis
Biomedicines 11(7) (2023)
Mona A. Omar; Mohamed M. Omran; Khaled Farid; Ashraf Abdou Tabll; Yasser Ezzat Shahein; Tarek Mostafa Emran; Ana G. Petrovic; Nikola Raguž Lučić; Robert Smolić; Tanja Kovac; Martina Smolić
The Future of Tumor Markers: Advancing Early Malignancy Detection Through Omics Technologies, Continuous Monitoring, and Personalized Reference Intervals
Biomolecules 15(7) (2025)
İrem Nur Savaş; Abdurrahman Coşkun
Osteopontin versus alpha-fetoprotein as a diagnostic marker for hepatocellular carcinoma: a meta-analysis
OncoTargets and Therapy Volume 11 (2018)
Tingting Sun; Yurong Tang; Di-wen Sun; Qingao Bu; Peng Li
Serum Midkine and Osteopontin Levels as Diagnostic Biomarkers of Hepatocellular Carcinoma
Electronic physician 9(1) (2017)
Hossam Hodeib; Ola A. Elshora; Amal Abd Elmoniem Selim; Nesreen Mohammed Sabry; Heba Elashry
Osteopontin in hepatocellular carcinoma: A possible biomarker for diagnosis and follow-up
Cytokine 99 (2017)
Manuela Cabiati; Melania Gaggini; Maria Michela Cesare; Chiara Caselli; Paolo DE SIMONE; Franco Filipponi; Giuseppina Basta; Amalia Gastaldelli; Silvia Del Ry
Diagnostic accuracy and prognostic significance of osteopontin in liver cirrhosis and hepatocellular carcinoma: a Meta-analysis
Biomarkers 27(1) (2021)
Yingshi Zhang; Jiayue Gao; Yu J. Bao; Yang Liu; Yimeng Tong; Shuqing Jin; Qingchun Zhao
Discovery of a Potential Plasma Protein Biomarker Panel for Acute-on-Chronic Liver Failure Induced by Hepatitis B Virus
Frontiers in Physiology 8 (2017)
Ni Zhou; Kuifeng Wang; Shanhua Fang; Xiaoyu Zhao; Tingting Huang; Huazhong Chen; Fei Yan; Yongzhi Tang; Hu Zhou; Jiansheng Zhu
Suppression of osteopontin inhibits chemically induced hepatic carcinogenesis by induction of apoptosis in mice
Oncotarget 7(52) (2016)
Su‐Hyung Lee; Junwon Park; Sang‐Ho Woo; Du‐Min Go; Hyo‐Jung Kwon; Ja‐June Jang; Dae-Yong Kim
Significance of biglycan and osteopontin as non-invasive markers of liver fibrosis in patients with chronic hepatitis B virus and chronic hepatitis C virus
Journal of Investigative Medicine 67(3) (2018)
Ali Sobhy; Fakhry M. Mohammed; A Azeem Haitham; Ahmed M. Ashmawy; Hamed O. Khalifa
Diagnostic accuracy of osteopontin plus alpha-fetoprotein in the hepatocellular carcinoma: A meta-analysis
Clinics and Research in Hepatology and Gastroenterology 41(5) (2017)
Jinwan Li; Xiaoli Chen; Meiyu Dai; Shifeng Huang; Jingfan Chen; Shengming Dai
Serum osteopontin predicts glycaemic profile improvement in metabolic syndrome: A pilot study
European Journal of Clinical Investigation 51(3) (2020)
Lara Caserza; Matteo Casula; Edoardo Elia; Aldo Bonaventura; Luca Liberale; Maria Bianca Bertolotto; Nathan Artom; Silvia Minetti; Paola Contini; Daniela Verzola; Roberto Pontremoli; Francesca Chiara Viazzi; Giorgio Luciano Viviani; Stefano Bertolini; Aldo Pende; Livia Pisciotta; Fabrizio Montecucco; Federico Carbone
Evaluation of click chemistry microarrays for immunosensing of alpha-fetoprotein (AFP)
Beilstein Journal of Nanotechnology 10 (2019)
Seyed Mohammad Mahdi Dadfar; Sylwia Sekula‐Neuner; Vanessa Trouillet; Huiyu Liu; Ravi Kapoor Kumar; Annie K. Powell; Michael Hirtz
A Study on the Serum γ-Glutamyltranspeptidase and Plasma Osteopontin in Alcoholic Liver Disease
Journal of Laboratory Physicians 14(02) (2021)
Arpita Suri; Naveen Kumar Singh; Sanjiv Kumar Bansal
Increased plasma osteopontin levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
Cytokine 125 (2019)
Cong Wang; Miao He; Jiajia Peng; Shengbing Li; Min Long; Wenwen Chen; Dongfang Liu; Gangyi Yang; Lili Zhang
Molecular diagnosis of hepatocellular carcinoma: trends in biomarkers combination to enhance early cancer detection
Hepatoma Research 2019 (2019)
Tiong Sun Chia; Kwong‐Fai Wong; John Moon Luk
A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma
Frontiers in Oncology 13 (2023)
Ti Yang; Yurong Luo; Junhao Liu; Fang Liu; Zengxin Ma; Gai Liu; Hailiang Li; Jianfan Wen; Chengcong Chen; Xiancheng Zeng
Diagnostic Accuracy of Plasma Osteopontin in Egyptian Hepatocellular Carcinoma Patients
Afro-Egyptian Journal of Infectious and Endemic Diseases 0(0) (2022)
Ehab Fawzy Abdo Mostafa; Hend Eltaher; Eman Nasr Eldin; Sahar Mohamed Hassany
Performance of SPINK1 and SPINK1‐based diagnostic model in detection of hepatocellular carcinoma
Journal of Clinical Laboratory Analysis 35(11) (2021)
Fang Wang; Hui Liu; Youxi Bai; Hui Li; Zhonglin Wang; Xin Xu
Biomarkers in Diagnosis and Prediction of Hepatocellular Carcinoma Recurrence (Review)
Современные технологии в медицине 11(2) (2019)
Sergey Igorevich Malov; И. В. Малов; В. В. Дворниченко; Patrice Noël Marche; Thomas Decaens; Zuzana Macek Jílková; N.D. Yushchuk
Serum osteopontin as a blood biomarker in relapsing–remitting multiple sclerosis Egyptian patients
The Egyptian Journal of Laboratory Medicine 33(1) (2021)
Dina L. Mohamed; Hanaa Ahmed Amer; Rania A. Abo‐Shady; Mohamed Aly Abdel Hafeez; Neama M. Lotfy
Role of annexin A2 and osteopontin for early diagnosis of hepatocellular carcinoma in hepatitis C virus patients
Egyptian Liver Journal 9(1) (2019)
Abdelfattah Hanno; Fatma Mohamed Abd El Aziz; Akram Abdel Moneim Deghady; Ehab H. El-Kholy; Aborawy I. Aborawy
Novel Mechanism of Nonalcoholic Lipid Accumulation Promoting Malignant Transformation of Hepatocytes
InTech eBooks (2018)
Min Yao; Wenjie Zheng; Li Wang; Miao Fang; Zhizhen Dong; Dengfu Yao
Role of Osteopontin as a Potential Marker of Hepatocellular Carcinoma
The Medical Journal of Cairo University/The Medical Journal of Cairo University 88(6) (2020)
M.D. AHMED E. EL-ALIM EHAB A. ELATTY; M.D. KHALED M. ELSAYED REEM M. ELKHOLY
ROLE OF OSTEOPONTIN AND DIKKOPF RELATED PROTEIN -1(DKK-1) AS DIAGNOSTIC MARKERS OF HCV RELATED HEPATOCELLULAR CARCINOMA
Al-Azhar Medical Journal 47(1) (2018)
Abdellah A. Omar; Ashraf Taha Abd Elmouttaleb; Ebrahim M. Bayomy; Gamal M. Soliman
The Predictive Role of Osteopontin Level in Patients with Type 2 Diabetes Mellitus without Fatty Liver Disease
Journal of the Faculty of Medicine Baghdad 66(1) (2024)
Qassim AlKenany; Manal Kamal Rasheed; Khalid A. J. AlKazraj